Primatope Therapeutics, Inc. — Form D
Primatope Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-03. The offering totals $400K, of which $400K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-12-03
- Form: D
- Accession: 0001593407-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $400K
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2011-11-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-207332
Issuer
- Name: Primatope Therapeutics, Inc.
- CIK: 0001593407
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 508 DUDLEY ROAD, NEWTON, MA, 02459
- Phone: 617-244-3885
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Keith Reimann | Director | Marblehead, MA |
| Mark Tepper | Director | Newton, MA |
| Mark Tepper | Executive Officer | Newton, MA |
More